Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder

Psychiatry Research

Volumn 119, Issue 1-2, 2003, Pages 11-24

  Soloff, Paul H ^a   Kelly, Thomas M ^a   Strotmeyer, Stephen J ^b   Malone, Kevin M ^c   Mann, J John ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Aggression; Prolactin; Serotonin; Suicide

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DELTA PROLACTIN; FENFLURAMINE; FLUOXETINE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PROLACTIN; PROLACTIN DERIVATIVE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; AGGRESSION; BORDERLINE STATE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG RESPONSE; FEMALE; GENDER; HISTORY; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCALE UP; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDE;

EID: 0038303755     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(03)00100-8     Document Type: Conference Paper

References (76)

1. Åsberg M., Nordström P., Träskman-Bendz L. Cerebrospinal fluid studies in suicide: an overview. Annals of the New York Academy of Sciences. 487:1986;243-255.
2. Barratt E.L. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychological Reports. 16:1965;547-554.
3. Beck A.T., Steer R.A. Manual for the Beck Hopelessness Scale. 1988;The Psychological Corporation, San Antonio, TX.
4. Beck A.T., Ward C.H., Mendelson M., Mosk J., Erlbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 4:1961;561-571.
5. Beck A.T., Schuyler D., Herman I. Development of suicidal intent scales. Beck A.T., Resnick H.L.P., Lettiem D. The Prediction of Suicide. 1974;45-56 Charles Press, Bowie, MD.
6. Beck A.T., Beck R., Kovacs M. Classification of suicidal behaviors I: quantifying intent and medical lethality. American Journal of Psychiatry. 132:1975;285-287.
7. Brodsky B.S., Malone K.M., Ellis S.P., Dulit R.A., Mann J.J. Characteristics of borderline personality disorder associated with suicidal behavior. American Journal of Psychiatry. 154:1997;1715-1719.
8. Brown G.L., Ebert M.H., Goyer P.F., Jimerson D.C., Klein W.J., Bunney W.E., Goodwin F.K. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. American Journal of Psychiatry. 139:1982;741-746.
9. Buss A.H., Durkee A. An inventory for assessing different kinds of hostility. Journal of Consulting and Clinical Psychology. 21:1959;343-349.
10. Cleare A.J., Bond A.J. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatry Research. 69:1997;89-95.
11. Cloninger, C.R., Przybeck, T.R., Svrakic, D.M., Wetzel, R.D., 1994. The Temperament and Character Inventory (TCI): a guide to its development and use. Center for Psychobiology of Personality, Washington University, St. Louis, MO.
12. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., Davis K.L. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry. 46:1989;587-599.
13. Coccaro E.F., Gabriel S., Siever L.J. Buspirone challenge: preliminary evidence for a role for central 5HT-1a receptor function in impulsive aggressive behavior in humans. Psychopharmacology Bulletin. 26:1990;393-405.
14. Coccaro E.F., Bergeman C.S., McClearn G.E. Heritability of irritable impulsiveness: a study of twins reared together and apart. Psychiatry Research. 48:1993;229-242.
15. Coccaro E.F., Berman M.E., Kavoussi R.J., Hauger R.L. Relationship of prolactin response to D-fenfluramine to behavioral and questionnaire assessments of aggression in personality disordered men. Biological Psychiatry. 40:1996;157-164.
16. DeBellis M., Baum A.S., Birmaher B., Keshavan M.S., Eccard C.H., Boring A.M., Jenkens F.J., Ryan N.D. Developmental traumatology. Part I: biological stress systems. Biological Psychiatry. 45:1999;1259-1270.
17. DeBellis M.D., Keshavan M.S., Clark D.B., Casey B.J., Giedd J.N., Boring A.M., Frustaci K., Ryan N.D. Developmental traumatology. Part II: brain development. Biological Psychiatry. 45:1999;1271-1284.
18. De la Fuente J.M., Goldman S., Stanus E., Vizuete C., Morlan I., Bobes J., Mendlewicz J. Brain glucose metabolism in borderline personality disorder. Journal of Psychiatric Research. 31:1997;531-541.
19. Driessen M., Hermann J., Stahl K., Zwaan M., Meier S., Hill A., Osterheider M., Peterson D. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Archives of General Psychiatry. 57:2000;1115-1122.
20. Evans J., Platts H., Lightman S., Nutt D. Impulsiveness and the prolactin response to D-fenfluramine. Psychopharmacology. 149:2000;147-152.
21. Gardner D.L., Lucas P.B., Cowdry R.W. CSF metabolites in borderline personality disorder compared with normal controls. Biological Psychiatry. 28:1990;247-254.
22. Gelernter J., Kranzler H., Coccaro E.F., Siever L.J., New A.S. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. American Journal of Psychiatry. 155:1998;1332-1338.
23. Gerra G., Zaimovic A., Timpano M., Zambelli U., Delsignore R., Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 25:2000;479-496.
24. Goyer P.F., Andreason P.J., Semple W.E., Clayton A.H., King A.C., Compton-Toth B.A., Schultz S.C., Cohen R.M. Positron-emission tomography and personality disorders. Neuropsychopharmacology. 10:1994;21-28.
25. Greenberg B.D., Li Q., Lucas F.R., Hu S., Sirota L.A., Benjamin J., Lesch K.-P., Hamer D., Murphy D.L. Association between serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. American Journal of Medical Genetics (Neuropsychiatric Genetics). 96:2000;202-216.
26. Hamilton M. A psychiatric rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 23:1960;56-62.
27. Hathoway S.R., Meehl P.E. The Atlas for the Clinical Use of the MMPI. 1951;University of Minnesota Press, Minneapolis.
28. Herpertz S., Sass H., Favazza A. Impulsivity in self-mutilative behavior: psychometric and biologic findings. Journal of Psychiatric Research. 31:(4):1997;451-465.
29. Hollander E., Stein D.J., DeCaria C.M., Cohen L., Saoud J.B., Skodol A.E., Kellman D., Rosnick L., Oldham J.M. Serotonergic sensitivity in borderline personality disorder: preliminary findings. American Journal of Psychiatry. 151:1994;277-280.
30. Kjelsberg E., Eikeseth P.H., Dahl A.A. Suicide in borderline patients - predictive factors. Acta Psychiatrica Scandinavica. 84:1991;283-287.
31. Krebs H.A., Chens L.K., Wright G.L. Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. Journal of Chromatography. 310:1984;412-417.
32. Kullgren G., Renberg E., Jacobssen L. An empirical study of borderline personality disorder and psychiatric suicides. Journal Nervous and Mental Disease. 174:1986;328-331.
33. Lesch K.-P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
34. Lidberg L., Åsberg M., Sundquist-Stensman U.B. 5-Hydroxyindolacetic acid levels in attempted suicides who have killed their children. Lancet. 2:1984;928.
35. Lidberg L., Tuck J.R., Åsberg M., Scalia-Tomba G.P., Bertilsson L. Homicide, suicide and CSF 5-HIAA. Acta Psychiatrica Scandinavica. 71:1985;230-236.
36. Linnoila M., DeJong J., Virkkunen M. Monoamines, glucose metabolism and impulse control. Psychopharmacology Bulletin. 25:1989;404-406.
37. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sciences. 33:1983;2609-2614.
38. Livesley W.J., Jang K.L., Vernon P.A. Phenotypic and genetic structure of traits delineating personality disorder. Archives of General Psychiatry. 55:1998;941-948.
39. Loranger A.W., Susman V.L., Oldham J.M., Russakoff L.M. The personality disorder examination: a preliminary report. Journal of Personality Disorders. 1:1987;1-3.
40. Malone K.M., Corbitt E.M., Li S., Mann J.J. Prolactin response to fenfluramine and suicide attempt lethality in major depression. British Journal of Psychiatry. 168:1996;324-329.
41. Mann J.J., Malone K.M. Cerebrospinal fluid amines and higher lethality suicide attempts in depressed inpatients. Biological Psychiatry. 41:1997;162-171.
42. Mann J.J., McBride P.A., Brown R.P., Linnoila M., Leon A.C., DeMeo M.D., Mieczkowski T.A., Meyers J., Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Archives of General Psychiatry. 49:(6):1992;442-446.
43. Mann J.J., McBride P.A., Malone K.M., DeMeo M., Keilp J. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology. 13:1995;53-64.
44. Mann J.J., Huang Y., Underwood M., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., Arango V. A sertotonin transporter gene promoter polymorphism (5HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry. 57:(8):1996;729-738.
45. Mann J.J., Waternaux C., Haas G.L., Malone K.M. Toward a clinical model of suicidal behavior in psychiatric patients. American Journal of Psychiatry. 156:(2):1999;181-189.
46. Manuck S.B., Flory J.D., McCaffery J.M., Matthews K.A., Mann J.J., Muldoon M.F. Aggression, impulsivity and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology. 19:1998;287-299.
47. Manuck S.B., Flory J.D., Ferrell R.E., Dent K.M., Mann J.J., Muldoon M.F. Aggression and anger related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biological Psychiatry. 45:1999;603-614.
48. Martial J., Paris J., Leyton M., Zweig-Frank H., Schwartz G., Teboul E., Thavundayil J., Larue S., Kin N.M.K., Nair N.P. Neuroendocrine study of serotonin function in female borderline personality disorder patients: a pilot study. Biological Psychiatry. 42:1997;737-739.
49. McBride P.A., Tierney H., DeMeo M., Chen J.-S., Mann J.J. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biological Psychiatry. 27:1990;1143-1155.
50. Mieczkowski T.A., Sweeney J.A., Haas G.L., Junker B.W., Brown R.P., Mann J.J. Factor composition of the Suicide Intent Scale. Suicide and Life Threatening Behavior. 23:1993;37-45.
51. Moss H.B., Yao J.K., Panzak L. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biological Psychiatry. 28:1990;325-338.
52. Muldoon M.F., Manuck S.B., Jansma C.L., Moore A.L., Perel J., Mann J.J. D,L Fenfluramine challenge test: experience in non-patient sample. Biological Psychiatry. 39:1996;761-768.
53. New A.S., Trestman R.L., Mitropoulou V., Benishay D., Coccaro E., Siever L.J. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Research. 69:(1):1997;17-26.
54. New A.S., Gelernter J., Yovell Y., Trestman R.L., Nielsen D.A., Silverman J., Mitropoulou V., Siever L.J. Tryptophan hydroxylase genotype is associated with impulsive aggression measures: a preliminary study. American Journal of Medical Genetics. 81:(1):1998;13-17.
55. O'Keane V., O'Hanlon M., Webb M., Dinan J. D-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an estrogen-induced alteration. Clinical Endocrinology. 34:1991;289-292.
56. O'Keane V., Maloney E., O'Neill H., O'Connor A., Smith C., Dinan T.G. Blunted prolactin responses to D-fenfluramine in sociopathy: evidence for subsensitivity of central serotonergic function. British Journal of Psychiatry. 160:1992;643-646.
57. Oquendo M.A., Mann J.J. The biology of impulsivity and suicidality. Psychiatric Clinics of North America. 23:(1):2000;11-25.
58. Paris J. Chronic suicidality among patients with borderline personality disorder. Psychiatric Services. 53:2002;738-742.
59. Raine D., Buchsbaum M.S., Stanley J., Lottenberg S., Abel L., Stoddard J. Selective reductions in pre-frontal glucose metabolism in murderers assessed with positron emission tomography. Psychophysiology. 29:(4A):1992;58.
60. Raine D., Buchsbaum M., LaCasse. Brain abnormalities in murderers indicated by positron emission tomography. Biological Psychiatry. 42:1997;495-508.
61. Reist C., Mazzanti C., Vu R., Tran D., Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. American Journal of Medical Genetics. 105:(4):2001;363-368.
62. Rinne T., Westenberg H.G.M., den Boer J.A., van den Brink W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biological Psychiatry. 47:2000;548-556.
63. Ruegg R.G., Gilmore J., Ekstrom R.D., Corrigan M., Knight B., Tancer M., Leatherman M.E., Carson S.W., Golden R.N. Clomipramine challenge responses co-vary with Tridimensional Personality Questionnaire scores in healthy subjects. Biological Psychiatry. 42:1997;1123-1129.
64. Siever L.J., Buchsbaum M., New A.S., Spiegel-Cohen J., Wei T., Hazlett E., Sevin E., Nunn M., Mitropoulou V. D,L Fenfluramine response in impulsive personality disorder assessed with [18-F] fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 20:1999;413-423.
65. Soloff P.H., Lis J.A., Kelly T., Cornelius J., Ulrich R. Risk factors for suicidal behavior in borderline personality disorder. American Journal of Psychiatry. 151:1994;1316-1323.
66. Soloff P.H., Lynch K.G., Kelly T.M., Malone K.M., Mann J.J. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. American Journal of Psychiatry. 157:2000;601-608.
67. Soloff P.H., Meltzer C.C., Greer P.J., Constantine D., Kelly T.M. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biological Psychiatry. 47:2000;540-547.
68. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Instruction Manual for the Structured Clinical Interview for DSM III-R (SCID). 1988;New York State Psychiatric Institute, Biometrics Research, New York.
69. Stanley M., Mann J.J. Biological factors associated with suicide. Frances A.J., Hales R.E. Review of Psychiatry, vol. 7. 1988;334-352 American Psychiatric Press, Washington, DC.
70. Stein D.J., Hollander E., DeCaria C.M., Simeon D., Cohen L., Aronowitz B. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Biological Psychiatry. 40:1996;508-513.
71. Stein M.B., Koverola C., Hanna C., Torchia M.G., McClarty B. Hippocampal volume in women victimized by sexual abuse. Psychological Medicine. 27:1997;951-959.
72. Stone M. The course of borderline personality disorder. Tasman A., Hales R.E., Frances A.J. Review of Psychiatry, vol. 8. 1989;103-122 American Psychiatric Press, Washington, DC.
73. Träskman-Benz L., Åsberg M., Schalling D. Serotonergic function and suicidal in personality disorders. Annals of the New York Academy of Sciences. 487:1986;174-188.
74. Virkkunen M., Nuutila A., Goodwin F.K., Linnoila M. Cerebrospinal fluid metabolites in male arsonists. Archives of General Psychiatry. 44:1987;241-247.
75. Virkkunen M., Rawlings R., Tokola R., Poland R.E., Guidotti A., Nemeroff C., Bissette G., Kalogeras K., Karonen S., Linnoila M. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Archives of General Psychiatry. 51:1994;20-27.
76. Widiger T.A., Weissman M.M. Epidemiology of borderline personality disorder. Hospital and Community Psychiatry. 42:1991;1015-1021.